Biden Administration Prioritizes Behavioral Health Telehealth Flexibilities to Expand Access and Improve Care
The Biden administration is signaling a strong commitment to preserving and expanding behavioral health telehealth flexibilities as a critical strategy to improve access to...
Federal Crackdown on Private Equity in Healthcare: What It Means for Behavioral Health Dealmaking
Federal agencies are increasingly focusing on Private Equity Healthcare Investigation, signaling potential changes that could reshape behavioral health dealmaking. In early March 2025, the...
A historic investment: how the Biden-Harris 2025 budget targets the substance use crisis in America
The Biden-Harris administration’s proposed 2025 federal budget marks a pivotal moment in the fight against substance use and opioid overdoses. With an unprecedented $21.8...
Outpatient Behavioral Health Leads the Pack in a Soft M&A Market
After several years of rapid growth, behavioral health dealmaking slowed down in 2023—but not across the board. While most segments saw a sharp drop...
Private Equity’s Growing Influence on Opioid Treatment Programs and What It Means for Methadone Access
A recent analysis by STAT highlights a significant development in the addiction treatment landscape: Private Equity Opioid Treatment Programs now control 562 methadone clinics...
FDA clearance is gaining traction in autism spectrum disorder interventions beyond traditional behavioral therapies
A growing number of startups are turning to the Food and Drug Administration (FDA) to validate innovative interventions for autism spectrum disorder (ASD) that...
